P.L. Thomas and HG&H Pharmaceuticals Slated for Full-Scale, Broad Market Launch of Clinically Supported Zembrin® Sceletium tortuosum at SupplySide West 2012
Study is the First to Test the Activity of Sceletium tortuosum on Brain Activity and the First to Study the Effects of a Dual PDE4 and 5-HT Reuptake Inhibitor in Humans
PLT Health Solutions, Inc announced the publication of a clinical study on its Boswellia serrata-based AprèsFlex 5-Day Joint Support ingredient that provides further evidence of its ability to support joint health and function with statistically significant improvements in pain scores and biomarkers starting at only 5 days from initial consumption.